国家肾脏基金会:推进移植可及性与结局的创新路线图
美国国家肾脏基金会召集专家小组,针对肾移植可及性与长期结局提出研究议程,重点包括扩大活体供肾、优化等待名单管理、最大化利用逝者供器官、减少器官丢弃、延长移植物存活及减轻终身免疫抑制负担,并特别关注儿童肾衰竭患者的移植可及性与移植物存活。
要点
- 优先研究扩大活体供肾、改善等待名单管理与移植准备。
- 需投资减少器官丢弃的策略,如教育接受非标准器官、新评估技术。
- 开发个体化策略减轻终身免疫抑制负担,追求「一次移植终身受益」。
核心结论
- 专家小组确定未来研究重点为扩大活体供肾、优化等待名单管理、最大化逝者供器官利用、延长移植物存活及减轻免疫抑制负担。
- 特别提出改善儿童肾衰竭患者移植可及性与移植物存活的目标。
研究设计与样本
- 美国国家肾脏基金会召集专家小组制定未来研究议程的立场声明。
主要发现
- 过去65年肾移植已成为肾衰竭最佳治疗,改善生存与生活质量,但可及性仍受器官供应限制且分布不均,长期移植物存活仍未解决。
临床怎么用
- 临床应关注教育患者与医生接受非标准器官的潜在获益,并利用新器官评估技术与实时决策支持减少器官丢弃。
- 探索移植前器官保存与复苏方法,并开发个体化策略减轻终身免疫抑制负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Over the past 65 years, kidney transplantation has evolved into the optimal treatment for patients with kidney failure, dramatically reducing suffering through improved survival and quality of life. However, access to transplant is still limited by organ supply, opportunities for transplant are inequitably distributed, and lifelong transplant survival remains elusive. To address these persistent needs, the National Kidney Foundation convened an expert panel to define an agenda for future research. The key priorities identified by the panel center on the needs to develop and evaluate strategies to expand living donation, improve waitlist management and transplant readiness, maximize use of available deceased donor organs, and extend allograft longevity. Strategies targeting the critical goal of decreasing organ discard that warrant research investment include educating patients and clinicians about potential benefits of accepting nonstandard organs, use of novel organ assessment technologies and real-time decision support, and approaches to preserve and resuscitate allografts before implantation. The development of personalized strategies to reduce the burden of lifelong immunosuppression and support "one transplant for life" was also identified as a vital priority. The panel noted the specific goal of improving transplant access and graft survival for children with kidney failure. This ambitious agenda will focus research investment to promote greater equity and efficiency in access to transplantation, and help sustain long-term benefits of the gift of life for more patients in need.
引用
- Lentine KL, Pastan S, Mohan S, et al. A Roadmap for Innovation to Advance Transplant Access and Outcomes: A Position Statement From the National Kidney Foundation. Am J Kidney Dis. 2021. PMID: 34330526. doi:10.1053/j.ajkd.2021.05.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。